Interactions of polymyxin B in combination with aztreonam, minocycline, meropenem and rifampicin against Escherichia coli producing NDM and OXA-48-group carbapenemases,Antimicrobial Agents and Chemotherapy

当前位置： X-MOL 学术 › Antimicrob. Agents Chemother. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Interactions of polymyxin B in combination with aztreonam, minocycline, meropenem and rifampicin against Escherichia coli producing NDM and OXA-48-group carbapenemases
Antimicrobial Agents and Chemotherapy ( IF 4.1 ) Pub Date : 2021-09-13 , DOI: 10.1128/aac.01065-21
Anna Olsson ₁ , Marcus Hong ₁ , Hissa Al-Farsi ₂ , Christian G Giske _{2,

3} , Pernilla Lagerbäck ₁ , Thomas Tängdén ₁

Affiliation

Objectives. Carbapenemase-producing Enterobacterales pose an increasing medical threat. Combination therapy is often used for severe infections; however, there is little evidence supporting the optimal selection of drugs. This study aimed to determine the ...

中文翻译：